Insider Transactions in Q1 2024 at Shattuck Labs, Inc. (STTK)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Redmile Group, LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
4,425
-0.08%
|
-
|
|
Mar 06
2024
|
Stephen Stout |
SELL
Open market or private sale
|
Direct |
16,004
-6.41%
|
$160,040
$10.53 P/Share
|
|
Mar 06
2024
|
Stephen Stout |
BUY
Exercise of conversion of derivative security
|
Direct |
11,109
+6.12%
|
$33,327
$3.54 P/Share
|
|
Jan 30
2024
|
Casi De Young Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,008
-2.19%
|
$18,072
$9.99 P/Share
|
|
Jan 30
2024
|
Abhinav A. Shukla Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,290
-2.8%
|
$20,610
$9.99 P/Share
|
|
Jan 30
2024
|
Stephen Stout |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-0.74%
|
$5,337
$9.99 P/Share
|
|
Jan 30
2024
|
Arundathy N. Pandite Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,920
-1.33%
|
$26,280
$9.99 P/Share
|
|
Jan 10
2024
|
Stephen Stout |
BUY
Grant, award, or other acquisition
|
Direct |
49,050
+38.03%
|
-
|
|
Jan 10
2024
|
Abhinav A. Shukla Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,425
+29.03%
|
-
|
|
Jan 10
2024
|
Andrew R Neill Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-12.6%
|
$250,000
$10.0 P/Share
|
|
Jan 10
2024
|
Andrew R Neill Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,470
-1.23%
|
$24,700
$10.09 P/Share
|
|
Jan 10
2024
|
Andrew R Neill Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,500
+21.95%
|
-
|
|
Jan 10
2024
|
Casi De Young Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,583
-1.7%
|
$15,830
$10.09 P/Share
|
|
Jan 10
2024
|
Casi De Young Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,200
+33.17%
|
-
|
|
Jan 10
2024
|
Arundathy N. Pandite Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,987
-1.34%
|
$29,870
$10.09 P/Share
|
|
Jan 10
2024
|
Arundathy N. Pandite Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,475
+17.29%
|
-
|